MGMT methylation in glioblastoma: tale of the tail

Neuro Oncol. 2015 Jan;17(1):167-8. doi: 10.1093/neuonc/nou319. Epub 2014 Nov 13.

Authors

Nameeta Shah¹, Brett Schroeder¹, Charles Cobbs¹

Affiliation

¹ The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, Washington.

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents, Alkylating / therapeutic use*
DNA Methylation*
DNA Modification Methylases / genetics*
DNA Repair Enzymes / genetics*
Dacarbazine / analogs & derivatives*
Dacarbazine / therapeutic use
Glioblastoma / drug therapy*
Glioblastoma / genetics*
Humans
Kaplan-Meier Estimate
Promoter Regions, Genetic
Temozolomide
Treatment Outcome
Tumor Suppressor Proteins / genetics*

Substances

Antineoplastic Agents, Alkylating
Tumor Suppressor Proteins
Dacarbazine
DNA Modification Methylases
MGMT protein, human
DNA Repair Enzymes
Temozolomide